Plimoth Trust CO LLC Regeneron Pharmaceuticals, Inc. Transaction History

Plimoth Trust CO LLC

$391 Million
Q3 2024

A detailed history of Plimoth Trust CO LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Plimoth Trust CO LLC holds 837 shares of REGN stock, worth $633,449. This represents 0.22% of its overall portfolio holdings.

Number of Shares

837

Previous 908 7.82%

Holding current value

$633,449

Previous $954,000 7.86%

% of portfolio

0.22%

Previous 0.26%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$1024.09 - $1201.76 $72,710 - $85,324	-71 Reduced 7.82%	837 $879,000
Q2 2024 Jul 23, 2024	SELL	$883.2 - $1071.19 $52,992 - $64,271	-60 Reduced 6.2%	908 $954,000
Q1 2024 Apr 18, 2024	SELL	$902.69 - $993.35 $148,041 - $162,909	-164 Reduced 14.49%	968 $931,000
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $1.03 Million - $1.17 Million	-1,324 Reduced 53.91%	1,132 $994,000
Q3 2023 Oct 20, 2023	SELL	$692.45 - $844.37 $130,180 - $158,741	-188 Reduced 7.11%	2,456 $2.02 Million
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $13,300 - $15,776	-19 Reduced 0.71%	2,644 $1.9 Million
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $27,219 - $33,078	40 Added 1.52%	2,663 $2.19 Million
Q4 2022 Jan 19, 2023	SELL	$705.89 - $766.39 $52,941 - $57,479	-75 Reduced 2.78%	2,623 $1.89 Million
Q3 2022 Oct 18, 2022	BUY	$573.97 - $724.32 $118,237 - $149,209	206 Added 8.27%	2,698 $1.86 Million
Q2 2022 Jul 15, 2022	BUY	$548.35 - $738.84 $242,370 - $326,567	442 Added 21.56%	2,492 $1.47 Million
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $7,736 - $9,079	13 Added 0.64%	2,050 $1.43 Million
Q4 2021 Jan 27, 2022	BUY	$543.48 - $670.97 $177,174 - $218,736	326 Added 19.05%	2,037 $1.29 Million
Q3 2021 Oct 22, 2021	BUY	$574.03 - $680.96 $114,231 - $135,511	199 Added 13.16%	1,711 $1.04 Million
Q2 2021 Jul 20, 2021	BUY	$472.8 - $558.54 $714,873 - $844,512	1,512 New	1,512 $844,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.

Account

Plimoth Trust CO LLC Regeneron Pharmaceuticals, Inc. Transaction History